Centessa Pharmaceuticals plc American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CNTA Company Description
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
CNTA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CNTA Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CNTA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CNTA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CNTA in WallStreetBets Daily Discussion
CNTA News
Recent insights relating to CNTA
CNBC Recommendations
Recent picks made for CNTA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CNTA
Corporate Flights
Flights by private jets registered to CNTA
Our Analysis